ArticleThe Biochemical journal2020

Rationally designed peptide-based inhibitor of Aβ42 fibril formation and toxicity: a potential therapeutic strategy for Alzheimer's disease.

John R Horsley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.